These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12794565)

  • 1. AIDS wasting syndrome: trends, influence on opportunistic infections, and survival.
    Dworkin MS; Williamson JM;
    J Acquir Immune Defic Syndr; 2003 Jun; 33(2):267-73. PubMed ID: 12794565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
    Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
    MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.
    Ledergerber B; Egger M; Erard V; Weber R; Hirschel B; Furrer H; Battegay M; Vernazza P; Bernasconi E; Opravil M; Kaufmann D; Sudre P; Francioli P; Telenti A
    JAMA; 1999 Dec; 282(23):2220-6. PubMed ID: 10605973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.
    Mocroft A; Sabin CA; Youle M; Madge S; Tyrer M; Devereux H; Deayton J; Dykhoff A; Lipman MC; Phillips AN; Johnson MA
    J Acquir Immune Defic Syndr; 1999 Aug; 21(5):401-7. PubMed ID: 10458621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of HIV infection in the era of combination antiretroviral therapy.
    Moore RD; Chaisson RE
    AIDS; 1999 Oct; 13(14):1933-42. PubMed ID: 10513653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends in clinical AIDS presentations and survival among HIV-1-infected women.
    Charurat M; Blattner W; Hershow R; Buck A; Zorrilla CD; Watts DH; Paul M; Landesman S; Adeniyi-Jones S; Tuomala R;
    J Womens Health (Larchmt); 2004; 13(6):719-30. PubMed ID: 15333287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV wasting syndrome.
    Reiter GS
    AIDS Clin Care; 1996 Nov; 8(11):89-91, 93, 96. PubMed ID: 11363990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of opportunistic disease on survival in patients with HIV infection.
    Chaisson RE; Gallant JE; Keruly JC; Moore RD
    AIDS; 1998 Jan; 12(1):29-33. PubMed ID: 9456252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trials for wasting drug.
    Posit Aware; 1996; 7(6):5-6. PubMed ID: 11363980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.
    Tanuma J; Lee KH; Haneuse S; Matsumoto S; Nguyen DT; Nguyen DT; Do CD; Pham TT; Nguyen KV; Oka S
    PLoS One; 2016; 11(3):e0150781. PubMed ID: 26939050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
    Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
    AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses.
    Conti S; Masocco M; Pezzotti P; Toccaceli V; Vichi M; Boros S; Urciuoli R; Valdarchi C; Rezza G
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):451-8. PubMed ID: 11141245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.
    Welch K; Morse A;
    AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to the AIDS Wasting Syndrome.
    Corcoran C
    Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting.
    Sherer R
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):92-7. PubMed ID: 9625390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment].
    Ledru é ; Sanou PT; Dembele M; Dahourou H; Zoubga A; Durand G
    Sante; 1999; 9(5):293-300. PubMed ID: 10657773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of clinical interventions for AIDS wasting.
    Beaston-Blaakman A; Shepard DS; Stone N; Shevitz AH
    AIDS Care; 2007 Sep; 19(8):996-1001. PubMed ID: 17851996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.
    Melkamu MW; Gebeyehu MT; Afenigus AD; Hibstie YT; Temesgen B; Petrucka P; Alebel A
    BMC Infect Dis; 2020 Jan; 20(1):50. PubMed ID: 31948393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.
    Muñoz A; Schrager LK; Bacellar H; Speizer I; Vermund SH; Detels R; Saah AJ; Kingsley LA; Seminara D; Phair JP
    Am J Epidemiol; 1993 Feb; 137(4):423-38. PubMed ID: 8096356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003.
    Tang AM; Jacobson DL; Spiegelman D; Knox TA; Wanke C
    J Acquir Immune Defic Syndr; 2005 Sep; 40(1):70-6. PubMed ID: 16123685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.